Skip to content
GLP-1 Decoder

Trulicity for Kidney Disease: Evidence, Eligibility

Trulicity is not FDA approved for kidney disease. It is approved for type 2 diabetes and heart risk.

For kidney disease
Not an approved use
Active ingredient
dulaglutide
How it is taken
weekly injection

Trulicity overview

How long it remains in the body
100%50%25%0%05 d10 d15 d20 d25 d50%25%12.5%time after the dose

Its half-life is about 5 days: after 5 d, half is gone, and about 3% remains after five half-lives (25 d).

Sources: FDA label (DailyMed).

Who qualifies?

Who qualifies for Trulicity
SourceWho qualifies
FDA labelFor adults and children 10 and older who have type 2 diabetes, this medicine lowers blood sugar when used with diet and exercise.
FDA labelIn adults who have type 2 diabetes plus heart disease or several heart risk factors, this medicine lowers the risk of a heart attack, stroke, or heart-related death.

Sources: FDA label (DailyMed).

Kidney disease: what is different?

Label details for Trulicity and kidney disease
What changesWhat the label says
Acute Kidney Injury Due to Volume DepletionFluid loss from vomiting or diarrhea may lead to kidney injury. Drink fluids and report heavy fluid loss.

The FDA labels say: FDA label (DailyMed).

The source of these label warnings is: FDA label (DailyMed).

Coverage for kidney disease

These medicines may be covered by Medicare Part D when the prescription is for diabetes or cardiovascular disease.

Sources: humana.com.

Other options for kidney disease:

GLP-1 medicines and kidney disease
MedicineFor kidney diseaseHow it is takenTrial result
OzempicFDA approvedweekly injectionthe risk of kidney failure, a major loss of kidney function, or death from kidney or heart causes was 24% lower
TrulicityNot an approved useweekly injectionNot listed
WegovyNot an approved useweekly injection or daily tabletNot listed
RybelsusNot an approved usedaily tabletNot listed
MounjaroNot an approved useweekly injectionNot listed
ZepboundNot an approved useweekly injectionNot listed
FoundayoNot an approved usedaily tabletNot listed
SaxendaNot an approved usedaily injectionNot listed
VictozaNot an approved usedaily injectionNot listed
ByettaNot an approved usetwice-daily injectionNot listed

Sources used: PubMed, FDA label (DailyMed).

Questions to ask your prescriber

For full prescribing details, see Trulicity on DailyMed.